Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults.

Garfield LD, Müller DJ, Kennedy JL, Mulsant BH, Reynolds CF 3rd, Teitelbaum SL, Civitelli R, Dixon D, Todorov AA, Lenze EJ.

World J Biol Psychiatry. 2014 Jul;15(5):404-10. doi: 10.3109/15622975.2013.832380. Epub 2013 Sep 30.

PMID:
24074042
[PubMed - in process]
2.

Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.

Shea ML, Garfield LD, Teitelbaum S, Civitelli R, Mulsant BH, Reynolds CF 3rd, Dixon D, Doré P, Lenze EJ.

Osteoporos Int. 2013 May;24(5):1741-9. doi: 10.1007/s00198-012-2170-z. Epub 2013 Jan 29.

PMID:
23358607
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Common Selective Serotonin Reuptake Inhibitor Side Effects in Older Adults Associated with Genetic Polymorphisms in the Serotonin Transporter and Receptors: Data from a Randomized Controlled Trial.

Garfield LD, Dixon D, Nowotny P, Lotrich FE, Pollock BG, Kristjansson SD, Doré PM, Lenze EJ.

Am J Geriatr Psychiatry. 2013 Sep 7. pii: S1064-7481(13)00291-1. doi: 10.1016/j.jagp.2013.07.003. [Epub ahead of print]

PMID:
24021217
[PubMed - as supplied by publisher]
4.

Escitalopram reduces attentional performance in anxious older adults with high-expression genetic variants at serotonin 2A and 1B receptors.

Lenze EJ, Dixon D, Nowotny P, Lotrich FE, Doré PM, Pollock BG, Hinrichs AL, Butters MA.

Int J Neuropsychopharmacol. 2013 Mar;16(2):279-88. doi: 10.1017/S1461145712000351. Epub 2012 Apr 17.

PMID:
22717018
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.

Murphy GM Jr, Hollander SB, Rodrigues HE, Kremer C, Schatzberg AF.

Arch Gen Psychiatry. 2004 Nov;61(11):1163-9.

PMID:
15520364
[PubMed - indexed for MEDLINE]
6.

Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder.

Stein MB, Seedat S, Gelernter J.

Psychopharmacology (Berl). 2006 Jul;187(1):68-72. Epub 2006 Mar 9.

PMID:
16525856
[PubMed - indexed for MEDLINE]
7.

Association study of novel human serotonin 5-HT(1B) polymorphisms with alcohol dependence in Taiwanese Han.

Sun HF, Chang YT, Fann CS, Chang CJ, Chen YH, Hsu YP, Yu WY, Cheng AT.

Biol Psychiatry. 2002 Jun 1;51(11):896-901.

PMID:
12022963
[PubMed - indexed for MEDLINE]
8.

Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and serotonin transporter promoter genotype (SLC6A4) influence executive functions at 6 years of age.

Weikum WM, Brain U, Chau CM, Grunau RE, Boyce WT, Diamond A, Oberlander TF.

Front Cell Neurosci. 2013 Oct 11;7:180. doi: 10.3389/fncel.2013.00180. eCollection 2013.

PMID:
24130516
[PubMed]
Free PMC Article
9.

Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial.

Denys D, Van Nieuwerburgh F, Deforce D, Westenberg HG.

J Clin Psychiatry. 2007 May;68(5):747-53.

PMID:
17503984
[PubMed - indexed for MEDLINE]
10.

Functional polymorphisms in the serotonin 1B receptor gene (HTR1B) predict self-reported anger and hostility among young men.

Conner TS, Jensen KP, Tennen H, Furneaux HM, Kranzler HR, Covault J.

Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):67-78. doi: 10.1002/ajmg.b.30955.

PMID:
19350534
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A.

Villafuerte SM, Vallabhaneni K, Sliwerska E, McMahon FJ, Young EA, Burmeister M.

Psychiatr Genet. 2009 Dec;19(6):281-91. doi: 10.1097/YPG.0b013e32832a506e.

PMID:
19829169
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL.

JAMA. 2005 May 18;293(19):2372-83. Review.

PMID:
15900008
[PubMed - indexed for MEDLINE]
13.

Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications.

Oberlander TF, Bonaguro RJ, Misri S, Papsdorf M, Ross CJ, Simpson EM.

Mol Psychiatry. 2008 Jan;13(1):65-73. Epub 2007 May 22.

PMID:
17519929
[PubMed - indexed for MEDLINE]
14.

A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions.

Sullivan PW, Valuck R, Saseen J, MacFall HM.

CNS Drugs. 2004;18(13):911-32.

PMID:
15521793
[PubMed - indexed for MEDLINE]
15.

Depression, antidepressants, and bone health in older adults: a systematic review.

Gebara MA, Shea ML, Lipsey KL, Teitelbaum SL, Civitelli R, Müller DJ, Reynolds CF 3rd, Mulsant BH, Lenze EJ.

J Am Geriatr Soc. 2014 Aug;62(8):1434-41. doi: 10.1111/jgs.12945. Epub 2014 Jul 15.

PMID:
25039259
[PubMed - in process]
16.

Estradiol and progesterone modify the effects of the serotonin reuptake transporter polymorphism on serotonergic responsivity to citalopram.

Michopoulos V, Berga SL, Wilson ME.

Exp Clin Psychopharmacol. 2011 Dec;19(6):401-8. doi: 10.1037/a0025008. Epub 2011 Aug 15.

PMID:
21843009
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogenetics.

Calarge CA, Ellingrod VL, Zimmerman B, Bliziotes MM, Schlechte JA.

J Clin Psychiatry. 2011 Dec;72(12):1685-90. doi: 10.4088/JCP.10m06198.

PMID:
22244026
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The integrated model of serotonin transporter gene variation (5HTTLPR) and the glial cell transporter in stress vulnerability and depression.

Shinozaki G.

Med Hypotheses. 2012 Mar;78(3):410-4. doi: 10.1016/j.mehy.2011.10.043. Epub 2012 Jan 10.

PMID:
22236459
[PubMed - indexed for MEDLINE]
19.

Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Foster RH, Goa KL.

CNS Drugs. 1997 Aug;8(2):163-88. doi: 10.2165/00023210-199708020-00010.

PMID:
23338224
[PubMed]
20.

Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults.

Lenze EJ, Goate AM, Nowotny P, Dixon D, Shi P, Bies RR, Lotrich FK, Rollman BL, Shear MK, Thompson PA, Andreescu C, Pollock BG.

J Clin Psychopharmacol. 2010 Dec;30(6):672-7.

PMID:
21105279
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk